1996
DOI: 10.1016/0142-9612(96)87284-x
|View full text |Cite
|
Sign up to set email alerts
|

Novel approach to fabricate porous sponges of poly(d,l-lactic-co-glycolic acid) without the use of organic solvents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
598
0
6

Year Published

1998
1998
2010
2010

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 1,001 publications
(615 citation statements)
references
References 10 publications
1
598
0
6
Order By: Relevance
“…A variety of matrix fabrication techniques including particulate leaching, [28] gas foaming, [29] phase separation, [30] and sphere sintering [31] have been developed to produce 3D porous matrices for skeletal tissue regeneration during the past two decades. It has been demonstrated that a porosity of ~90% is highly desirable for an ideal scaffold by providing sufficient space for extracellular matrix (ECM) synthesis, a high surface area for cell–material interactions, and minimal diffusion constraints.…”
Section: Discussionmentioning
confidence: 99%
“…A variety of matrix fabrication techniques including particulate leaching, [28] gas foaming, [29] phase separation, [30] and sphere sintering [31] have been developed to produce 3D porous matrices for skeletal tissue regeneration during the past two decades. It has been demonstrated that a porosity of ~90% is highly desirable for an ideal scaffold by providing sufficient space for extracellular matrix (ECM) synthesis, a high surface area for cell–material interactions, and minimal diffusion constraints.…”
Section: Discussionmentioning
confidence: 99%
“…Although this technique has advanced the overall science of controlled drug delivery in tissue engineering, unintended release of residual solvent trapped in the polymer after processing is harmful to adherent cells, local growth factors, and neighboring tissue. 221,[313][314][315][316][317][318] Residual organic solvents in a polymer scaffold limit or prevent the encapsulation of active growth factors and hence functionality of the scaffold. Therefore, novel solvent-free techniques are being aggressively pursed.…”
Section: Antibiotics and Chemotherapeuticsmentioning
confidence: 99%
“…Therefore, novel solvent-free techniques are being aggressively pursed. Some examples of solvent-free scaffold fabrication techniques include: sintering/compression followed by ultrasonic welding, 264,285 hot melt encapsulation, 313,315,319 high pressure CO 2,314 and mechanical mixing. In hot melt encapsulation, the processing temperature must be below the denaturation or deactivation temperature of the bioactive molecule or drug encapsulated.…”
Section: Antibiotics and Chemotherapeuticsmentioning
confidence: 99%
“…An overall rating was obtained using weighting factors (53 for the capsular thickness, 33 for the cellular response observed in the capsule, 53 for the neutrophils, 23 for the FBGCs, 13 for the lymphocytes, 13 for macrophages, and 13 for the fibroblasts). Reactions were classified into 6 categories, which were as follows: no reaction (0), minimal (1-10), slight (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25), moderate (26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40), marked (41-60), and excessive (>60).…”
Section: Histological Evaluationmentioning
confidence: 99%
“…Use of supercritical CO 2 allows the incorporation of biological agents and ceramic particles, and the manufacture of open pore foams with low intrinsic viscosity amorphous PLGA (polylactic-co-glycolic acid). [38][39][40] In this study we focused on semicrystalline PLA, which allowed us obtaining open pore scaffolds with controlled porosity and morphology and improved mechanical properties, thus creating for bone cells an environment similar to natural bone.…”
Section: Introductionmentioning
confidence: 99%